tiprankstipranks
Advertisement
Advertisement

TSHA Stock Latest News

Taysha Gene Therapies price target raised to $11 from $8 at Citizens
The FlyTaysha Gene Therapies price target raised to $11 from $8 at Citizens
1h ago
TSHA
Taysha Completes REVEAL Dosing, Advances Rett Gene Therapy
PremiumCompany Announcements
Taysha Completes REVEAL Dosing, Advances Rett Gene Therapy
22h ago
8K
TSHA
Taysha Gene Therapies completes dosing in REVEAL pivotal trial
PremiumThe Fly
Taysha Gene Therapies completes dosing in REVEAL pivotal trial
23h ago
TSHA
Taysha Gene Therapies Shareholders Back Governance and Leadership
PremiumCompany Announcements
Taysha Gene Therapies Shareholders Back Governance and Leadership
21d ago
8K
TSHA
ASPIRE Rett Syndrome Trial Puts Taysha’s TSHA-102 Gene Therapy in Focus for Investors
PremiumCompany Announcements
ASPIRE Rett Syndrome Trial Puts Taysha’s TSHA-102 Gene Therapy in Focus for Investors
1M ago
TSHA
FDA Commissioner Marty Makary resigns
PremiumThe FlyFDA Commissioner Marty Makary resigns
1M ago
AZN
BMY
Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA
Premium
Company Announcements
Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA
1M ago
TSHA
Whitney Ijem Reiterates Buy Rating and Maintains $17 Price Target on Clinical Momentum and Strong Cash Runway
Premium
Ratings
Whitney Ijem Reiterates Buy Rating and Maintains $17 Price Target on Clinical Momentum and Strong Cash Runway
2M ago
TSHA
Taysha Gene Therapies reports Q1 EPS (12c), consensus (10c)
PremiumThe Fly
Taysha Gene Therapies reports Q1 EPS (12c), consensus (10c)
2M ago
TSHA
Unusually active option classes on open April 16th
PremiumThe Fly
Unusually active option classes on open April 16th
2M ago
PEP
BULL
Buy Rating on Taysha Gene Therapies Driven by Strong Leadership, Strategic Positioning, and Attractive Risk‑Reward Upside
PremiumRatings
Buy Rating on Taysha Gene Therapies Driven by Strong Leadership, Strategic Positioning, and Attractive Risk‑Reward Upside
2M ago
TSHA
Advancing Gene Therapy Programs and Strengthened Valuation Support Taysha Buy Rating and $17 Target
PremiumRatings
Advancing Gene Therapy Programs and Strengthened Valuation Support Taysha Buy Rating and $17 Target
3M ago
TSHA
Taysha Gene Therapies price target raised to $17 from $14 at Canaccord
PremiumThe FlyTaysha Gene Therapies price target raised to $17 from $14 at Canaccord
3M ago
TSHA
Taysha Gene Therapies Signals Momentum in Earnings Call
Premium
Company Announcements
Taysha Gene Therapies Signals Momentum in Earnings Call
3M ago
TSHA
Taysha Gene Therapies reports 2025 EPS (34c), consensus (34c)
Premium
The Fly
Taysha Gene Therapies reports 2025 EPS (34c), consensus (34c)
3M ago
TSHA
Taysha Gene Therapies management to meet with Cantor
PremiumThe Fly
Taysha Gene Therapies management to meet with Cantor
3M ago
TSHA
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
PremiumThe Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
4M ago
TSHA
TSHA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
TSHA Earnings this Week: How Will it Perform?
4M ago
TSHA
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
PremiumThe Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
5M ago
TSHA
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
PremiumWeekend UpdatesAehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
5M ago
RF
ABEO
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
Premium
Ratings
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
6M ago
TSHA
Taysha Gene Therapies announces progress across TSHA-102
Premium
The Fly
Taysha Gene Therapies announces progress across TSHA-102
6M ago
TSHA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >